NASC OTC
Nascent Pharma Holdings, Inc.
1W: -10.0%
1M: +12.5%
3M: -40.0%
YTD: -40.0%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$167K
+77.5% ▲
Operating Income
-$2M
+48.6% ▲
Net Income
-$5M
+53.2% ▲
EPS (Diluted)
$-0.06
+67.1% ▲
EBITDA
-$2M
+69.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $0 |
| YoY Growth | +0.0% |
| Cost of Revenue | $167K |
| Gross Profit | -$167K |
| Gross Margin | — |
| R&D Expenses | $0 |
| SG&A Expenses | $2M |
| Operating Expenses | $2M |
| Operating Income | -$2M |
| Operating Margin | — |
| Interest Expense | $2M |
| Income Before Tax | -$5M |
| Tax Expense | $0 |
| Net Income | -$5M |
| Net Margin | — |
| EPS (Diluted) | $-0.06 |
| EBITDA | -$2M |
| Shares Outstanding | 85M |